Literature DB >> 19254475

Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host.

F Xiao-Feng Qin1.   

Abstract

Regulatory T cells (Tregs) expressing forkhead/winged-helix transcription factor Foxp3 represent a distinct lineage of lymphocytes which play a central role in protecting the host from autoimmune diseases. However, Tregs also pose a major problem to anti-tumor immunity. Growing body of evidence from both laboratory and clinical investigations has demonstrated that expansion and accumulation of these immunosuppressive cells correlates with advanced tumor growth and predicts poor disease prognosis. How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive. This review will discuss our current knowledge in understanding the dynamics and plasticity of Foxp3+ Treg activation and induction in tumor bearing hosts and their interaction with various antigen presenting cells (APCs) in tumor microenvironment leading to the establishment of active local and systemic immune suppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254475      PMCID: PMC4002545          DOI: 10.1038/cmi.2009.2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  27 in total

1.  Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.

Authors:  William W Tseng; Daniel Winer; Justin A Kenkel; Okmi Choi; Alan H Shain; Jonathan R Pollack; Randy French; Andrew M Lowy; Edgar G Engleman
Journal:  Clin Cancer Res       Date:  2010-06-09       Impact factor: 12.531

2.  The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.

Authors:  David Coe; Caroline Addey; Matthew White; Elizabeth Simpson; Julian Dyson; Jian-Guo Chai
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

3.  Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Authors:  Rachel F Gabitass; Nicola E Annels; Deborah D Stocken; Hardev A Pandha; Gary W Middleton
Journal:  Cancer Immunol Immunother       Date:  2011-06-05       Impact factor: 6.968

4.  MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.

Authors:  Hussein Fayyad-Kazan; Redouane Rouas; Mohammad Fayyad-Kazan; Rabih Badran; Nabil El Zein; Philippe Lewalle; Mehdi Najar; Medhi Najar; Eva Hamade; Fadi Jebbawi; Makram Merimi; Pedro Romero; Arsène Burny; Bassam Badran; Philippe Martiat
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 5.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

6.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

7.  Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Authors:  Jinlin Liu; Ning Zhang; Qun Li; Weiwei Zhang; Fang Ke; Qibin Leng; Hong Wang; Jinfei Chen; Honglin Wang
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.

Authors:  Ai-Xia Dou; Li-Li Feng; Xiao-Qian Liu; Xin Wang
Journal:  Cell Mol Immunol       Date:  2012-09-24       Impact factor: 11.530

Review 9.  Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.

Authors:  Huijuan Cheng; Guodong Sun; Hao Chen; Yu Li; Zhijian Han; Yangbing Li; Peng Zhang; Luxi Yang; Yumin Li
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 10.  Harnessing DNA-induced immune responses for improving cancer vaccines.

Authors:  Andrés A Herrada; Nicole Rojas-Colonelli; Paula González-Figueroa; Jonathan Roco; César Oyarce; Maarten A Ligtenberg; Alvaro Lladser
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.